Target intelligence / Profile preview

TRIB1 associated long noncoding RNA (TRIB1AL)

Target
TRIB1AL
Molecular classification
Long noncoding RNA (lncRNA), Non-protein-coding RNA
01

Overview

TRIB1 associated long noncoding RNA (TRIB1AL, also called TRIBAL) is a long noncoding RNA transcript located near the TRIB1 gene on chromosome 8q24.13, encompassing key genetic risk loci for plasma triglyceride levels and coronary artery disease. TRIB1AL contains a conserved promoter and is transcribed into multiple splice variants with no coding potential for protein. Risk SNPs in its promoter region are associated with altered promoter activity, changes in TRIB1 expression, and plasma lipid traits. TRIBAL appears to function partly through regulation of TRIB1 expression and downstream biochemical pathways in hepatocytes, including lipid metabolism and liver-specific transcriptional regulation, but also displays elements of functional independence from nearby protein-coding genes. Elevated or reduced TRIBAL expression, as well as specific promoter SNPs, are associated with dyslipidemia, increased cardiovascular disease risk, and hepatic metabolic changes. No drugs target TRIBAL directly, and its importance is mainly as a locus modulating disease risk via genetic and expression effects.

Other names
TRIB1ALTRIBALTRIB1-associated locus
02

Mechanism of action

No therapeutics with a mechanism of action targeting TRIB1-associated lncRNA have been described. Risk single-nucleotide polymorphisms (SNPs) in the TRIBAL locus likely affect gene expression and downstream lipid metabolism, but not through drug-like action.

03

Biological functions

Regulation of gene expression in the liver and possibly other tissuesModulation of hepatic triglyceride metabolismImpacts cholesterol and lipid homeostasisSupports hepatocyte functionInteracts with TRIB1 to influence expression of key hepatic regulators such as HNF4A and lipid metabolic genes
04

Disease associations

Coronary artery diseaseDyslipidemia (including elevated plasma triglycerides and reduced HDL cholesterol)Hepatic steatosis (fatty liver disease)Potential atherogenic (plaque-formation) processes
05

Safety considerations

No safety concerns are directly related to TRIB1-associated lncRNA as a therapeutic target; it is a disease risk gene, not a druggable molecule.
06

Biomarkers

SNPs such as rs2001844 and rs6982502 in the TRIB1AL promoter are risk markers for plasma triglyceride concentration and coronary artery diseaseVariation in TRIBAL expression and these SNPs may serve as genetic biomarkers of cardiovascular and metabolic risk, but are not yet used in routine clinical biomarker panels

Beyond the preview

Go deeper on TRIB1 associated long noncoding RNA (TRIB1AL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRIB1 associated long noncoding RNA (TRIB1AL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call